GeminIQ Website Logo

Viewing MNKD free

Subscribe for full history, 90+ metrics, screener, watchlist...

MANNKIND CORP

MNKD

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial
Subscriber-only column
Developed Technology Rights
------1-----
In Process Research And Development
--4---4-----
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value
535375127574746629719323883
Short Term Investments
5881961331221341511891511075758
Accounts Receivable Net Current
432838172729121823201522
Inventory Net
444935272829282725262927
Prepaid Expense And Other Assets Current
474047544434313130363536
Assets Current
246251292359279274268328326383373226
Restricted Cash
111111111---
Long Term Investments
--526221751713473
Property Plant And Equipment Net
858382838384858585848480
Goodwill
686868222222222
Intangible Assets Net Excluding Goodwill
555555551111
Other Assets Noncurrent
172220192028272616778
Assets
732744792495412410394464444481475320
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current
111697105761071017
Accrued Liabilities Current
615965313140403741424232
Finance Lease Liability Current
---------101010
Convertible Notes Payable Current
--36363636------
Business Combination Contingent Consideration Liab…
342421---------
Contract With Customer Liability Current
1112151011121277894
Liabilities Current
14313517110911211682728010010496
Contract With Customer Liability Noncurrent
373940484547516566687069
Operating Lease Liability Noncurrent
10101110111112123444
Finance Lease Liability Noncurrent
-------00949494
Convertible Long Term Notes Payable
------36228228227227226
Business Combination Contingent Consideration Liab…
-55---------
Long Term Loans Payable
31931931873--------
Liabilities
800804843539467469473674670711721572
Stockholders Equity
Common Stock Value
333333333333
Additional Paid In Capital Common Stock
3,1613,1503,1423,1323,1293,1263,1192,9962,9922,9862,9812,976
Accumulated Other Comprehensive Income Loss Net Of…
-0-0001111---0
Retained Earnings Accumulated Deficit
-3,232-3,213-3,196-3,180-3,188-3,189-3,202-3,209-3,221-3,219-3,229-3,231
Stockholders Equity
-67-59-51-45-55-59-79-210-226-230-246-252
Liabilities And Stockholders Equity
732744792495412410394464444481475320
Preferred Stock Par Or Stated Value Per Share
0.010.010.010.010.010.010.010.010.010.010.010.01
Preferred Stock Shares Authorized
101010101010101010101010
Preferred Stock Shares Issued
000000000000
Preferred Stock Shares Outstanding
000000000000
Common Stock Par Or Stated Value Per Share
0.010.010.010.010.010.010.010.010.010.010.010.01
Common Stock Shares Authorized
800800800800800800800800800800800800
Common Stock Shares Issued
310309308307306304303276274271270270
Shares Outstanding
310309308307306304303276274271270270

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
20265.90%16.29%16.01%---------
2025-10.37%-18.79%-12.31%32.28%59.37%53.03%-11.72%-4.46%-9.90%-23.77%-12.35%-4.63%
20246.14%18.64%32.95%24.95%23.75%30.54%-8.25%-7.71%-18.40%-4.57%-17.00%-20.11%
2023---0.65%-10.22%-15.00%-0.79%-4.21%-11.84%30.16%10.58%21.43%

Earnings Market Reaction data beyond 3 years is for subscribers only.

Unlock the full earnings market reaction history

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Metric history beyond 3 years is for subscribers only.

Unlock 17+ years of history across 90+ calculated metrics

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
1.72
1.87
1.70
3.29
2.50
2.36
3.28
4.54
4.07
3.84
3.59
2.34
Quick Ratio
1.08
1.20
1.23
2.54
1.84
1.82
2.55
3.74
3.39
3.21
2.98
1.69
Working Capital
102.81M
116.60M
120.55M
249.71M
167.20M
157.80M
186.47M
255.56M
245.93M
283.21M
269.27M
129.20M
Leverage & Debt
Debt to Equity
-11.90
-13.58
-16.53
-12.10
-8.48
-8.00
-6.00
-3.21
-2.97
-3.09
-2.93
-2.27
Interest Coverage TTM
0.33
0.89
2.81
9.29
8.06
5.56
6.06
4.12
3.28
2.10
0.57
-0.66
Debt Ratio
1.09
1.08
1.06
1.09
1.13
1.14
1.20
1.45
1.51
1.48
1.52
1.79
Efficiency & Turnover
Asset Turnover TTM
0.69
0.62
0.59
0.65
0.71
0.67
0.66
0.68
0.66
0.58
0.52
0.57
Days Sales Outstanding TTM
32.62
28.85
26.24
20.69
30.54
29.93
17.07
27.32
37.57
32.20
29.08
46.84
Receivables Turnover TTM
11.19
12.65
13.91
17.64
11.95
12.19
21.38
13.36
9.71
11.34
12.55
7.79
Per Share Metrics
Diluted EPS TTM
-0.14
-0.08
0.02
0.09
0.11
0.09
0.10
0.08
0.04
0.03
-0.04
-0.10
Free Cash Flow Per Share TTM
-0.06
0.04
0.04
0.14
0.09
0.07
0.12
0.10
0.07
0.01
-0.03
-0.12
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Gross Profit Margin TTM
83.56%
84.78%
82.47%
88.00%
84.10%
80.46%
79.27%
75.16%
77.63%
79.52%
78.94%
94.26%
Operating Profit Margin TTM
2.34%
4.11%
11.12%
23.26%
22.15%
26.26%
25.42%
20.19%
18.64%
13.98%
4.36%
-6.78%
Net Profit Margin TTM
-11.08%
-6.63%
1.68%
9.32%
10.87%
10.12%
9.66%
8.07%
4.73%
3.78%
-6.00%
-17.72%
Growth Metrics
Net Revenue Growth (1Y)
30.46%
21.23%
22.23%
17.44%
21.48%
32.50%
43.50%
51.35%
57.08%
74.92%
99.42%
131.61%
Net Income Growth (1Y)
-232.98%
-179.41%
-78.75%
35.55%
179.42%
254.85%
-331.09%
-168.93%
-124.74%
-111.92%
-86.34%
-67.92%
EPS Growth (1Y)
-231.16%
-178.17%
-80.92%
21.49%
150.19%
216.12%
-324.86%
-167.36%
-124.07%
-111.64%
-86.85%
-69.04%
Valuation Metrics
P/E TTM
-30.20
-31.58
295.58
56.36
34.77
50.69
63.96
80.20
121.43
144.30
-81.41
-35.47
P/B TTM
-19.60
-12.76
-33.97
-36.98
-20.72
-26.04
-22.39
-8.24
-6.31
-5.33
-3.95
-4.41
P/S TTM
3.35
2.09
4.97
5.25
3.78
5.13
6.18
6.47
5.74
5.45
4.89
6.29
Market Cap
1.32B
755.25M
1.73B
1.65B
1.14B
1.53B
1.76B
1.73B
1.43B
1.22B
971.93M
1.11B
Enterprise Value
1.26B
702.42M
1.69B
1.56B
1.12B
1.52B
1.75B
1.90B
1.56B
1.36B
1.06B
1.36B
Calculated Values
Free Cash Flow TTM
-18.14M
13.15M
13.69M
43.39M
28.79M
21.82M
32.82M
28.87M
18.24M
3.10M
-8.35M
-31.62M
Net Debt
-52.93M
-52.83M
-38.60M
-91.17M
-20.84M
-11.20M
-10.29M
165.74M
131.12M
138.02M
92.50M
247.59M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2026-05-12Sale
Owner: Thomson, David
Title: EVP Genl Counsel & Secretary
Shares: 3,033
Price/Share: $3.29
Value: $9,978.57
Shares Owned: 826,299
Relationship: Officer
Ownership: Direct
2026-05-12Sale
Owner: Binder, Steven B.
Title: -
Shares: 16,940
Price/Share: $3.29
Value: $55,732.60
Shares Owned: 808,008
Relationship: Director
Ownership: Direct
2026-03-10Purchase
Owner: Castagna, Michael
Title: Chief Executive Officer
Shares: 100,000
Price/Share: $2.59
Value: $259,000.00
Shares Owned: 2,575,911
Relationship: Director,Officer
Ownership: Direct
2026-01-08Sale
Owner: Tross, Stuart A
Title: Chief People & Workpl Officer
Shares: 47,006
Price/Share: $6.33
Value: $297,547.98
Shares Owned: 985,007
Relationship: Officer
Ownership: Direct
2025-12-17Sale
Owner: Castagna, Michael
Title: Chief Executive Officer
Shares: 65,804
Price/Share: $6.01
Value: $395,482.04
Shares Owned: 2,504,792
Relationship: Director,Officer
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
57.94%
Inst. Shares: 178,618,903
Shares Outstanding: 308,267,000
2025-12-31
58.82%
Inst. Shares: 179,778,646
Shares Outstanding: 305,639,000
2025-09-30
56.07%
Inst. Shares: 172,016,068
Shares Outstanding: 306,806,000
2025-06-30
54.86%
Inst. Shares: 167,283,077
Shares Outstanding: 304,954,000
2025-03-31
57.10%
Inst. Shares: 173,292,383
Shares Outstanding: 303,481,000

MANNKIND CORP (MNKD) — SEC Financial Statements & Analysis

MANNKIND CORP (MNKD) is a pharmaceutical preparations company, incorporated in DE. MANNKIND CORP trades on Nasdaq as: MNKD. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), MANNKIND CORP reported a 30.46% year-over-year revenue growth, a Gross Profit Margin of 83.56% (TTM), a Debt-to-Equity ratio of -11.90x, a Price-to-Sales (P/S) ratio of 3.35x (TTM), a Price-to-Book (P/B) ratio of -19.60x (TTM), at a market cap of $1.32B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
30.46%
Gross Profit Margin TTM
83.56%
Debt To Equity
-11.90x
P/S TTM
3.35x
P/B TTM
-19.60x
Market Cap
$1.32B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is MANNKIND CORP in?

MANNKIND CORP (MNKD) operates in the Pharmaceutical Preparations industry.

What is MNKD's market cap?

MANNKIND CORP (MNKD) has a market capitalization of $1.32B as of 2026-06-30.

What exchange does MNKD trade on?

MANNKIND CORP (MNKD) trades on the Nasdaq.

Where is MANNKIND CORP incorporated?

MANNKIND CORP is incorporated in DE.

Wall Street's data.
Main Street's price.